Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 3
2014 4
2015 1
2018 1
2019 1
2021 1
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors.
Lütgendorf-Caucig C, Pelak M, Hug E, Flechl B, Surböck B, Marosi C, Mock U, Zach L, Mardor Y, Furman O, Hentschel H, Gora J, Fossati P, Stock M, Graichen U, Klee S, Georg P. Lütgendorf-Caucig C, et al. Among authors: flechl b. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1206-1216. doi: 10.1016/j.ijrobp.2024.01.007. Epub 2024 Jan 18. Int J Radiat Oncol Biol Phys. 2024. PMID: 38244874 Free article.
The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy.
Lütgendorf-Caucig C, Pelak M, Flechl B, Georg P, Fossati P, Stock M, Traub-Weidinger T, Marosi C, Haberler C, Zechmeister-Machhart G, Hermsmeyer L, Hug E, Staudenherz A. Lütgendorf-Caucig C, et al. Among authors: flechl b. Strahlenther Onkol. 2023 Apr;199(4):396-403. doi: 10.1007/s00066-022-02010-4. Epub 2022 Oct 19. Strahlenther Onkol. 2023. PMID: 36260109
Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma.
Handisurya A, Rumpold T, Caucig-Lütgendorf C, Flechl B, Preusser M, Ilhan-Mutlu A, Dieckmann K, Widhalm G, Grisold A, Wöhrer A, Hainfellner J, Ristl R, Kurz C, Marosi C, Gessl A, Hassler M. Handisurya A, et al. Among authors: flechl b. Radiother Oncol. 2019 Jan;130:139-148. doi: 10.1016/j.radonc.2018.10.014. Epub 2018 Oct 30. Radiother Oncol. 2019. PMID: 30389240
18 results